The Impact of Myasthenia Gravis in the Real World
NCT04176211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2847
Last updated 2024-06-03
Summary
An international, non-interventional, prospective, community recruited, longitudinal, lifestyle study which aims to collect Real-World Evidence (RWE) from people living with myasthenia gravis (MG) in order to map the disease's natural history, its burden on patients and their families, its treatment, as well as its medical, social and pharmacoeconomic impact.
Conditions
Sponsors & Collaborators
-
Vitaccess Ltd
lead INDUSTRY
Principal Investigators
-
Mark JW Larkin, PhD · Vitaccess Ltd
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-12
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Myasthenia Gravis Registry in China
NCT06241521 ·Status: RECRUITING
-
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
NCT07146425 ·Status: RECRUITING
-
A Prospective Cohort Study Of Myasthenia Gravis
NCT04674605 ·Status: UNKNOWN
-
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
NCT05408702 ·Status: COMPLETED
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
Disease-Modifying Treatments for Myasthenia Gravis
NCT03490539 ·Status: COMPLETED
-
Vitaccess Real MG Registry
NCT06064461 ·Status: RECRUITING
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3
-
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
NCT06381284 ·Status: COMPLETED
-
The EXPLORE MG Registry for Myasthenia Gravis
NCT03792659 ·Status: RECRUITING
-
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
NCT00727194 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients
NCT05311904 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
NCT02473952 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
NCT03052751 ·Status: COMPLETED ·Phase: PHASE2
-
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
NCT02066519 ·Status: COMPLETED ·Phase: NA
-
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
NCT04535843 ·Status: RECRUITING
-
Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
NCT07224386 ·Status: NOT_YET_RECRUITING
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
NCT06064695 ·Status: RECRUITING ·Phase: NA
-
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
NCT04202341 ·Status: RECRUITING
-
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
NCT04590716 ·Status: COMPLETED
-
Immune Profiles in Myasthenia Gravis
NCT05095103 ·Status: UNKNOWN
-
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
NCT07217509 ·Status: ENROLLING_BY_INVITATION
-
Education Program in Myasthenia
NCT04714658 ·Status: UNKNOWN ·Phase: NA
-
Clinical Prognosis and Progression of Myasthenia Gravis Patients
NCT04101578 ·Status: UNKNOWN
-
BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
NCT02110706 ·Status: COMPLETED ·Phase: PHASE2